SPDR S&P Pharmaceuticals ETF $XPH Shares Bought by UBS Group AG

UBS Group AG raised its stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 33.2% in the 4th quarter, HoldingsChannel.com reports. The fund owned 47,961 shares of the company’s stock after purchasing an additional 11,948 shares during the period. UBS Group AG’s holdings in SPDR S&P Pharmaceuticals ETF were worth $2,686,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently bought and sold shares of the stock. SVB Wealth LLC raised its holdings in SPDR S&P Pharmaceuticals ETF by 1.7% during the third quarter. SVB Wealth LLC now owns 41,689 shares of the company’s stock worth $1,999,000 after purchasing an additional 677 shares in the last quarter. Advisory Services Network LLC purchased a new position in SPDR S&P Pharmaceuticals ETF during the third quarter worth about $34,000. Team Financial Group LLC purchased a new position in SPDR S&P Pharmaceuticals ETF during the fourth quarter worth about $56,000. JPMorgan Chase & Co. raised its holdings in SPDR S&P Pharmaceuticals ETF by 2.5% during the third quarter. JPMorgan Chase & Co. now owns 58,699 shares of the company’s stock worth $2,814,000 after purchasing an additional 1,441 shares in the last quarter. Finally, Park Avenue Securities LLC raised its holdings in SPDR S&P Pharmaceuticals ETF by 18.8% during the fourth quarter. Park Avenue Securities LLC now owns 12,014 shares of the company’s stock worth $673,000 after purchasing an additional 1,903 shares in the last quarter.

SPDR S&P Pharmaceuticals ETF Stock Up 0.5%

NYSEARCA XPH opened at $58.08 on Wednesday. The stock has a market capitalization of $357.19 million, a P/E ratio of 14.28 and a beta of 0.61. SPDR S&P Pharmaceuticals ETF has a 52-week low of $40.01 and a 52-week high of $60.73. The firm has a 50-day moving average price of $56.32 and a 200 day moving average price of $55.72.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.